文献速递前列腺癌

根治性前列腺切除术后出院阿片类药物处方前瞻性队列研究:ORIOLES倡议

A Prospective Cohort Study of Postdischarge Opioid Practices After Radical Prostatectomy: The ORIOLES Initiative.
PubMed 文献 · Eur Urol · 2018-10-21

ORIOLES是一项前瞻性队列研究(2017-2018),纳入205例根治性前列腺切除术后连续患者,随访完成率100%,旨在评估出院阿片类药物处方与实际使用及临床预测因素。结果显示中位处方量225mg口服吗啡当量(OMEQ),实际使用22.5mg,77%药物未使用,84%患者使用≤112.5mg OMEQ,仅9%妥善处置剩余药物。处方更多阿片类药物与使用量增加独立相关。

要点

  • 根治性前列腺切除术后中位处方225mg OMEQ,实际使用仅22.5mg。
  • 77%阿片类药物未使用,84%患者使用≤112.5mg OMEQ。
  • 仅9%患者妥善处置剩余药物,处方量越大使用越多。

核心结论

  • 根治性前列腺切除术后出院阿片类药物处方量远超实际需求,77%药物未被使用。
  • 处方更多阿片类药物与更大使用量独立相关,仅9%患者妥善处置剩余药物。

研究设计与样本

  • ORIOLES为前瞻性队列研究(2017-2018),纳入205例根治性前列腺切除术后连续成人患者。
  • 随访完成率100%,旨在建立满足>80%患者需求的出院阿片类药物参考值并比较开放与机器人手术。

主要发现

  • 以口服吗啡当量(OMEQ)计,中位处方量225mg,中位使用量22.5mg。
  • 手术方式或疼痛相关诊断史患者间无差异。
  • 77%出院阿片类药物未使用,84%患者使用≤112.5mg OMEQ。
  • 仅9%患者妥善处置剩余药物。
  • 约5%患者在30天报告因手术持续切口疼痛,但无人需继续使用阿片类药物。

关键数值与推荐

  • 84%患者使用≤112.5mg OMEQ,可作为满足>80%患者需求的参考值。
  • 调整模型中,处方更多阿片类药物与更大使用量独立相关。

临床怎么用

  • 可参考84%患者使用≤112.5mg OMEQ的数据,优化出院阿片类药物处方量。
  • 应加强患者剩余药物妥善处置的教育,仅9%患者正确处置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Opioid pain medications are overprescribed, but few data are available to help in appropriate tailoring of postdischarge opioid prescriptions after surgery. Prior studies are retrospective and based on incomplete responses (<50%) to questionnaires, with small sample sizes for any particular surgery. The ORIOLES initiative was a prospective cohort study (2017-2018) designed to measure postdischarge opioid prescribing and use and clinical predictors of use for consecutive patients after radical prostatectomy. The objectives were to establish a postdischarge opioid reference value to meet the needs of >80% of patients and compare open and robotic surgery. A total of 205 adult patients were enrolled, with 100% completing follow-up. In units of oral morphine equivalents (OMEQ), a median of 225mg was prescribed and 22.5mg used. There was no difference by surgical approach or among patients with a history of pain-related diagnoses. Overall, 77% of postdischarge opioid medication was unused, with 84% of patients requiring ≤112.5mg OMEQ. Only 9% of patients appropriately disposed of leftover medication. Approximately 5% reported continued incisional pain due to surgery at 30d, but none required continued opioid medication use. Prescribing more opioids was independently associated with greater opioid use in adjusted models. PATIENT SUMMARY: In this report, we looked at opioid medication use following discharge after radical prostatectomy. We found that 77% of opioid pain medication prescribed was unused, with 84% of patients using less than half of their prescription. Prescribing more opioids was associated with greater use; only 9% of patients appropriately disposed of leftover medication.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Patel HD, Srivastava A, Patel ND, et al. A Prospective Cohort Study of Postdischarge Opioid Practices After Radical Prostatectomy: The ORIOLES Initiative. Eur Urol. 2018. PMID: 30352714. doi:10.1016/j.eururo.2018.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。